Costa Rica - Average costs (US$), effects and cost-effectiveness of breast cancer control scenarios per year.

a<p>All costs in this table are in 2009 US$ (1CRC = 0,001784 US$).</p>b<p>DALYs, disability-adjusted life-years (age weighted, discounted).</p>c<p>ACER: Average cost-effectiveness ratio compared to the do nothing-scenario (US$ per DALY averted).</p>d<p>ICER: Incremental cost effectiveness ratio, ratio of additional cost per additional life-year saved when next intervention is added to a mix on the intervention path (additional US$ per additional DALY saved).